Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Stomatitis 9Neoplasms 6Head and Neck Neoplasms 4Multiple Myeloma 2Mucositis 2Leukemia 2Xerostomia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Oral Ulcer 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Laryngeal Diseases 1Hematologic Neoplasms 1Graft vs Host Disease 1Deglutition Disorders 1Colonic Neoplasms 1Cataract 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 4Cetuximab 4pembrolizumab 3Radiotherapy 2Pemetrexed 2N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2monalizumab 1capmatinib 1Vitamin B 12 1Tirapazamine 1Tablets 1Radiotherapy, Intensity-Modulated 1LY2940680 1Folic Acid 1Fibroblast Growth Factor 7 1Combined Modality Therapy 1Carboplatin 1Bleomycin 1Allovectin-7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Laryngeal Diseases × Fibroblast Growth Factor 7 × Clear all
NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Swedish Orphan Biovitrum

Phase 3 Completed
188 enrolled 19 charts
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡